Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03317756 · ClinicalTrials.gov registry record · NA

CONfident Treatment Decisions in Living With Rheumatoid Arthritis

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
208
Enrollment target

NCT03317756: Completed NA study, sponsored by University of Alabama at Birmingham.

NCT03317756 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 208 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03317756, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
208 participants
Enrollment target

Study Summary

Pilot test the novel educational patient-directed intervention to demonstrate the feasibility of the novel educational approaches developed in improving patient's willingness to achieve remission or low disease activity in RA.

Primary Outcome

Name of Scale: Choice predisposition scale The scale measures the willingness to change medication. The scale is a 11-point likert type scale that is scored from not willing at all (minimum) to extremely willing (maximum) with an unsure option (neutral). Higher scores (closer to the maximum) indicate a willingness to change medication and desire to further improve their RA disease activity.

Interventions

  • OTHER Patient Educational Intervention
  • OTHER Patient Control

Trial Details

FieldValue
Enrollment Target 208 participants
Start Date 2018-03-07
Est. Completion 2020-09-01
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT03317756 record still lists

NCT03317756 is an interventional study that assigns participants to a tested intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 2 interventions - of which Patient Educational Intervention is the first listed.

NCT03317756 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03317756 about?

NCT03317756 is a clinical study titled "CONfident Treatment Decisions in Living With Rheumatoid Arthritis". Pilot test the novel educational patient-directed intervention to demonstrate the feasibility of the novel educational approaches developed in improving patient's willingness to achieve remission or low disease activity in RA.

What is the current status of trial NCT03317756?

This trial is currently completed. It is a NA study. The enrollment target is 208 participants. The study started on 2018-03-07. Estimated completion is 2020-09-01.

What interventions are being tested in trial NCT03317756?

The interventions under investigation include: Patient Educational Intervention (OTHER), Patient Control (OTHER).

Who is sponsoring clinical trial NCT03317756?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03317756's enrollment target sits among peer trials

208 496th of 2000 higher than 1,502 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03465774 · 208 participants

    Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions

  • NCT03803332 · 208 participants · NA

    A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel

  • NCT04732065 · 208 participants · Phase 1

    ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

  • NCT05293756 · 208 participants · NA

    OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03317756, the US trial registry maintained by the National Library of Medicine. NCT03317756 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.